Preferential policy towards biological drugs

CVZ regards biological drugs as therapeutically interchangeable if they are designated as "similar" after being registered by the EMA or the CBG. Based on the system of the Zorgverzekeringswet [Zvw, Health Insurance Act], there is no reason for regarding these drugs as having any differences.

This report is a summary of recommendations by the National Health Care Institute. The original text is in Dutch.